Projects per year
Projects
- 5 Finished
Search results
-
Finished
Using an injectable hydrogel for the sustained systemic release of bioinspired cell-free secretome to alleviate diabetic kidney damage
Ricardo, S. (Primary Chief Investigator (PCI)) & Del Borgo, M. (Chief Investigator (CI))
1/07/21 → 30/06/22
Project: Research
-
Synthesis of novel peptide mimics for use as anti-fibrotic agents
Del Borgo, M. (Primary Chief Investigator (PCI)) & Widdop, R. (Chief Investigator (CI))
Monash University – Internal University Contribution, Monash University – Internal Department Contribution, Monash University – Internal Faculty Contribution
8/03/21 → 4/03/22
Project: Research
-
Novel inhibitors of SARS coronaviruses targeting ACE2
Drummer, H. (Primary Chief Investigator (PCI)), Widdop, R. (Chief Investigator (CI)), Aguilar, M. (Chief Investigator (CI)), Shehabi, Y. (Chief Investigator (CI)), Del Borgo, M. (Chief Investigator (CI)), Coulibaly, F. (Chief Investigator (CI)), McMahon, J. (Chief Investigator (CI)), Kulkarni, K. (Chief Investigator (CI)), Lambert, P. (Chief Investigator (CI)) & McIntosh, M. (Chief Investigator (CI))
1/06/20 → 28/02/21
Project: Research
-
Does selective angiotensin AT2 receptor stimulation protect against end organ extracellular matrix damage in diabetic hypertensives?
Widdop, R. (Primary Chief Investigator (PCI)), Del Borgo, M. (Chief Investigator (CI)), Aguilar, M. (Chief Investigator (CI)), Samuel, C. (Chief Investigator (CI)) & Wang, Y. (Chief Investigator (CI))
1/01/20 → 31/12/20
Project: Research
-
Protecting diabetic organs using a dual-acting compound delivered via injectable hydrogel
Ricardo, S. (Primary Chief Investigator (PCI)), Widdop, R. (Chief Investigator (CI)), Aguilar, M. (Chief Investigator (CI)), Del Borgo, M. (Chief Investigator (CI)) & Wilkinson-Berka, J. (Chief Investigator (CI))
Breakthrough T1D (United States of America)
1/11/17 → 30/11/22
Project: Research